NIR‐II Fluorescent Nanotheranostics with a Switchable Irradiation Mode for Immunogenic Sonodynamic Therapy
Advanced Materials · 2024
DOI: 10.1002/adma.202411328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Minhui Cui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry Chinese Academy of Sciences, …. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Nanoparticles. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: International Partnership Program of Chinese Academy of Sciences for Future Network, National Key Research & Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Nanotheranostics, which integrate diagnostic and therapeutic functionalities, offer significant potential for tumor treatment. However, current nanotheranostic systems typically involve multiple molecules, each providing a singular diagnostic or therapeutic function, leading to challenges such as complex structural composition, poor targeting efficiency, lack of spatiotemporal control, and dependence on a single therapeutic modality. This study introduces NP RBOXA , a nanoparticle functionalized with surface‐bound cRGD for targeted delivery to α v β 3 /α v β 5 receptors on tumor cells, achieving theranostic integration by sequentially switching its irradiation modes. Under 808 nm laser irradiation, NP RBOXA emits NIR‐II fluorescence, which aids in identifying the nanoparticle's location and fluorescence intensity, thereby determining the optimal treatment window. Following this, the irradiation mode switches to ultrasound irradiation at the optimal treatment window. Ultrasound irradiation induces NP RBOXA to generate reactive oxygen species, promoting the reduction of OXA‐IV to OXA‐II, which in turn triggers immunogenic cell death. This mechanism enables a combination of sonodynamic therapy, chemotherapy, and immunotherapy for tumor treatment. The versatile design of NP RBOXA holds promise for advancing precision oncology through enhanced therapeutic efficacy and real‐time imaging guidance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry, Institute of Chemistry Chinese Academy of Sciences, Beijing, 100190, P. R. China.
- University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
- Sydney Dental School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.
- Charles Perkins Centre, The University of Sydney, Camperdown, NSW, 2006, Australia.
ORCID-Profile: Haihua Xiao
Förderung
- International Partnership Program of Chinese Academy of Sciences for Future Network
- National Key Research & Development Program
- National Natural Science Foundation of China
Zitieren
APA
Cui, M., Tang, D., Zhang, H., Liang, G., Xu, C., & Xiao, H. (2024). NIR‐II Fluorescent Nanotheranostics with a Switchable Irradiation Mode for Immunogenic Sonodynamic Therapy. Advanced Materials. https://doi.org/10.1002/adma.202411328
Vancouver
Cui M, Tang D, Zhang H, Liang G, Xu C, Xiao H. NIR‐II Fluorescent Nanotheranostics with a Switchable Irradiation Mode for Immunogenic Sonodynamic Therapy. Advanced Materials. 2024. doi:10.1002/adma.202411328
BibTeX
@article{Cui2024,
author = {Cui, Minhui and Tang, Dongsheng and Zhang, Hanchen and Liang, Ganghao and Xu, Chun and Xiao, Haihua},
title = {NIR‐II Fluorescent Nanotheranostics with a Switchable Irradiation Mode for Immunogenic Sonodynamic Therapy},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202411328}
}
EUVIMED